Publications

Dernières Publications

Titre, auteurs, référence

09/2016

Lipid Nanoparticles for Reviving Antibiotics: Efficacy of a Gel of Daptomycin in a Methicillin-Resistant Staphylococcus aureus Rabbit Osteomyelitis Model. Jacqueline, C. & Reghal, A. & Asehnoune, K. & Potel, G. & Caillon, J. (2016).. ASM MICROBE 2016 - June 16-20, Boston (MA).


11/2014

Impact of bacterial biofilm on the treatment of prosthetic joint infections. C. Jacqueline and J. Caillon.  J. Antimicrob Chemother, Journal of Antimicrobial Chemotherapy. 09/2014; 69 Suppl 1:i37-i40.


05/2014

Daptomycin is more Bactericidal than Vancomycin and Vancomycin/Rifampin Combination in a Murine Model of Methicillin-Resistant Staphylococcus aureus Vascular Material Infection. M. Revest, C. Jacqueline, J. Caillon, P. Tattevin, G. Potel, C. Michelet, D. Boutoille. ECCMID 2014. Poster P 0089.


04/2014

Linezolid Dampens Neutrophil-Mediated Inflammation in Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia and Protects the Lung of Associated Damages. Cédric Jacqueline, Alexis Broquet, Antoine Roquilly, Marion Davieau, Jocelyne Caillon, Frédéric Altare, Gilles Potel, Karim Asehnoune. J Infect Dis. 2014 Apr 10.


10/2013

In vivo activity of Ceftaroline (CPT) alone and in combination with Avibactam (AV)I against beta-lactamase-producing Gram-negative Enterobacteriaceae: a comparative study with Doripenem (DOR) using a Murine Model of Urinary Tract Infection (UTI). C. Jacqueline, C. Desessard, X. Maquin, V. Le Mabecque, A. Lefort, F. Chau, G. Williams, G. Potel, J. Caillon. ICAAC 2013. Poster E-1172


09/2012

50% Effective dose (ED50) Determination of KPI-10 for Treating Sepsis in Mice Due to Fluoroquinolone-Susceptible (FQ-S) and Fluoroquinolone-Resistant (FQ-R) Nosocomial Pathogens: Comparison with Ciprofloxacin (CIP). C. Jacqueline, M. Davieau, C. Desessard, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° F-2056.


09/2012

In Vitro Bactericidal Activity of KPI-10, a Next Generation Fluoroquinolone (FQ), Against FQ-Susceptible (FQ-S) and FQ-Resistant (FQ-R) Gram-Negative and Gram-Positive Isolates. C. Jacqueline, C. Desessard, M. Davieau, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° E-203.


09/2012

Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response. C. Jacqueline, A. Roquilly, C. Desessard, D. Boutoille, A. B. V. Le Mabecque, G. Amador, G. Potel, J. Caillon and K. Asehnoune J. Antimicrob Chemother, 2012 Aug.


09/2012

Systemic Exposure Profile and Tissue Penetration (Lung, Kidney, Bone Marrow, and Gallblader) in Rabbits After KPI-10 Intravenous Administration. C. Jacqueline, V. Le Mabecque, C. Desessard, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° A-1948.


08/2012

A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment. A. Gaudin, C. Jacqueline,H. Gautier, C. Desessard, V. Le Mabecque, A.-F. Miegeville, G. Potel, J.-M. Bouler, P. Weiss, J. Caillon, G. Amador. Eur J Clin. Microbiol Infect Dis. Published online 25 August 2012


04/2012

Efficacy of ceftaroline fosamil in combination with the non-beta-lactam beta-lactamase inhibitor avibactam against ampC-producing Enterobacter cloacae: comparative study with doripenem in a rabbit experimental endocarditis model. C. Jacqueline, C. Bretonniere, V. Le Mabecque, C. Desessard, G. Amador, A.F. Miegeville, G. Williams, G. Potel, J. Caillon. ECCMID 2012. n° P 2065.


03/2012

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. L. Dubé, J. Caillon, C. Jacqueline, D. Bugnon, G. Potel, N. Asseray. Eur J Clin Microbiol Infect Dis published 8 march 2012


03/2012

Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. C. Bretonnière, C. Jacqueline, J. Caillon, C. Guitton, C. Desessard, V. Le Mabecque, A.F. Miégeville, D. Villers, G. Potel, D. Boutoille J Antimicrob Chemother. 2012 Mar;67(3): 780-1.


09/2011

In Vivo Activity of CXA-101 Against Pseudomonas aeruginosa(PA) in a Rabbit Experimental Model of Pneumonia: Comparison with Ceftazidime (CAZ), Piperacillin/Tazobactam (TZP), and Imipenem (IMP). C. Jacqueline, C. Bretonniere, C. Desessard, V. Le Mabecque, D. Boutoille, G. Potel, J. Caillon. ICAAC 2011.  Poster n° B-590.


09/2011

In vivo Contribution of a Filling Biomaterial Loaded with Linezolid in an Acute MRSA Osteomyelitis Model: time-dependent efficacy study about a new drug delivery system. G. Amador, A. Gaudin, V. Le Mabecque, A. Miegeville, G. Potel, J. Bouler, P. Weiss J. Caillon, C. Jacqueline. ICAAC 2011. Poster n° B-596.


04/2011

Diffusion of ofloxacin in the endocarditis vegetation assessed with synchrotron radiation UV fluorescence microspectroscopy. Batard E, Jamme F, Villette S, Jacqueline C, de la Cochetière MF, Caillon J, Réfrégiers M. PLoS One. 2011 Apr 29; 6 (4)


04/2011

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G. J Antimicrob Chemother. 2011 Apr; 66 (4): 863-6


03/2011

A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit. Gaudin A, Amador Del Valle G, Hamel A, Le Mabecque V, Miegeville AF, Potel G, Caillon J, Jacqueline C. Lett Appl Microbiol. 2011 Mar; 52 (3): 253-7.


12/2010

Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. Lefebvre M, Jacqueline C, Amador G, Le Mabecque V, Miegeville A, Potel G, Caillon J, Asseray N. Int J Antimicrob Agents. 2010 Dec; 36 (6): 542-4.


11/2010

Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. Bretonnière C, Jacqueline C, Caillon J, Guitton C, Le Mabecque V, Miégeville AF, Villers D, Potel G, Boutoille D. J Antimicrob Chemother. 2010 Nov; 65 (11): 2423-7.


10/2010

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model. Jacqueline C, Caillon J, Batard E, Le Mabecque V, Amador G, Ge Y, Biek D, Potel G. J Antimicrob Chemother. 2010 Oct; 65 (10): 2264-5


09/2010

ED50 Determination of CXA-101 Alone and in Combination with Tazobactam (TAZ) for Treating Experimental Peritonitis in Mice Due to ESBL-Producing Klebsiella pneumonia (KP) Strains: Comparison with Ceftazidime (CAZ) and Piperacillin/Tazobactam (TZP). C. Jacqueline,  C. Desessard, G. Amador, E. Batard, A. F. Miegeville,  J. Y. Ge, G. Potel , J. Caillon. ICAAC 2010. Poster n° B-708.


09/2010

Assessment of the In Vivo Activity of CXA-101 in a Murine Model of Pseudomonas aeruginosa Pneumonia: Comparison with Ceftazidime and Piperacillin-Tazobactam. C. Jacqueline,  C. Desessard, A. Roquilly, V. Le Mabecque, D. Boutoile, J. Y. Ge, K. Asehnoune , J. Caillon, G. Potel. ICAAC 2010. Poster n° B-1401.


09/2010

Efficacy of Daptomycin Against Staphylococcus epidermidis in an In Vitro-Infected Fibrin Clot Model: Comparison with Vancomycin. M. Briere, J. Caillon, C. Jacqueline,  A. F. Miegeville,  G. Potel , E. Batard. ICAAC 2010. Poster n° E-1553.


08/2010

Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. Jacqueline C, Amador G, Caillon J, Le Mabecque V, Batard E, Miègeville AF, Biek D, Ge Y, Potel G, Hamel A. J Antimicrob Chemother. 2010 Aug; 65 (8): 1749-52.


02/2010

In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model. Amador G, Gautier H, Le Mabecque V, Miegeville AF, Potel G, Bouler JM, Weiss P, Caillon J, Jacqueline C. Antimicrob Agents Chemother. 2010 Feb; 54 (2): 950-2.


02/2010

Influence of the AtlE autolysin on the activity of cell wall-active agents against Staphylococcus epidermidis. Hello M, Caroff N, Jacqueline C, Caillon J, Potel G, Batard E. Int J Antimicrob Agents. 2010 Feb;35(2):204-6.


12/2009

In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin. Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Ge Y, Biek D, Batard E, Potel G. Antimicrob Agents Chemother. 2009 Dec; 53 (12)


09/2009

FIC Index Determination of CXA-101 (CXA)/Tazobactam (TAZ) in Combination with Amikacin (AMK), Aztreonam (ATM), Meropenem (MEM), Levofloxacin (LVX), and Tigecycline (TGC) against Escherichia coli (EC), Klebsiella pneumoniae (KP), and Pseudomonas aeruginosa (PA) Strains. C. Jacqueline, C. Desessard, Y. Ge, G. Potel, J. Caillon. ICAAC 2009. Poster n° F1-1995.


05/2009

In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection. Boutoille D, Jacqueline C, Le Mabecque V, Potel G, Caillon J. Int J Antimicrob Agents. 2009 May; 33 (5): 417-20


12/2008

Intermittent active motion versus immobilization in the treatment of Staphylococcus aureus-induced arthritis in a rabbit model. Hamel A, Caillon J, Jacqueline C, Batard E, Boutoille D, Bugnon D, Miégeville AF, Rogez JM, Potel G. J Child Orthop. 2008 Dec; 2 (6): 491-5.


06/2008

Internal device decreases antibiotic's efficacy on experimental osteomyelitis. Hamel A, Caillon J, Jacqueline C, Rogez JM, Potel G. J Child Orthop. 2008 Jun; 2 (3): 239-43.


02/2008

Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model. Hamel A, Caillon J, Jacqueline C, Batard E, Potel G. Int J Antimicrob Agents. 2008 Feb; 31(2): 158-60.


09/2007

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G. Antimicrob Agents Chemother. 2007 Sep; 51 (9): 3397-400.


09/2007

In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model. Grossi O, Caillon J, Arvieux C, Jacqueline C, Bugnon D, Potel G, Hamel A. Antimicrob Agents Chemother. 2007 Sep; 51 (9): 3401-3.


07/2006

In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. Jacqueline C, Caillon J, Grossi O, Le Mabecque V, Miegeville AF, Bugnon D, Batard E, Potel G. Antimicrob Agents Chemother. 2006 Jul; 50 (7): 2547-9.


07/2005

In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsilon-caprolactone) microparticles. Le Ray AM, Gautier H, Laty MK, Daculsi G, Merle C, Jacqueline C, Hamel A, Caillon J. Antimicrob Agents Chemother. 2005 Jul; 49 (7): 3025-7.


06/2005

Eagle effect in Corynebacterium diphtheriae. Grandière-Pérez L, Jacqueline C, Lemabecque V, Patey O, Potel G, Caillon J. J Infect Dis. 2005 Jun 15; 191 (12): 2118-20.


02/2005

Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy. Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J. Antimicrob Agents Chemother. 2005 Feb; 49 (2): 857-9.


01/2005

In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Jacqueline C, Navas D, Batard E, Miegeville AF, Le Mabecque V, Kergueris MF, Bugnon D, Potel G, Caillon J. Antimicrob Agents Chemother. 2005 Jan; 49 (1): 45-51.


01/2005

Influence of carbon dioxide on the MIC of telithromycin for Streptococcus pneumoniae: an in vitro-in vivo study. Batard E, Juvin ME, Jacqueline C, Bugnon D, Caillon J, Potel G, Drugeon HB. Antimicrob Agents Chemother. 2005 Jan; 49 (1): 464-6


10/2004

Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G. J Antimicrob Chemother. 2004 Oct; 54 (4): 767-71.


10/2004

In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Jacqueline C, Asseray N, Batard E, Le Mabecque V, Kergueris MF, Dube L, Bugnon D, Potel G, Caillon J. Int J Antimicrob Agents. 2004 Oct; 24 (4): 393-6.


11/2003

Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. Dubé L, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Granry JC, Potel G, Bugnon D. Antimicrob Agents Chemother. 2003 Nov; 47 (11): 3663-6.


04/2003

In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G. J Antimicrob Chemother. 2003 Apr;51 (4): 857-64


12/2002

In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Jacqueline C, Batard E, Perez L, Boutoille D, Hamel A, Caillon J, Kergueris MF, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 Dec; 46 (12): 3706-11.


10/2002

In vivo activity of amoxicillin in a non-toxigenic Corynebacterium diphtheriae rabbit endocarditis experimental model. Grandière-Perez L, Jacqueline C, Le Mabecque V, Patey O, Potel G, Bugnon D, Caillon J. Pathol Biol (Paris). 2002 Nov; 50 (9): 513-5.


07/2002

Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study. Batard E, Jacqueline C, Boutoille D, Hamel A, Drugeon HB, Asseray N, Leclercq R, Caillon J, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 Jul; 46 (7): 2174-8.


05/2002

Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Asseray N, Caillon J, Roux N, Jacqueline C, Bismuth R, Kergueris MF, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 May; 46 (5): 1591-3.